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Endoscopic sinus surgeryAbstract Introduction: Functional endoscopic sinus surgery (FESS) is one of the operations that
need controlled hypotension. Many drugs were successfully used in this purpose, e.g., magnesium
sulfate, esmolol, and volatile anesthetics. Hypotension was observed to occur after submucosal
injection of lidocaine. Based on this observation, it was hypothesized in this double-blinded ran-
domized controlled study that lidocaine may be effective in producing controlled hypotension.
Methods: Forty-eight ASA I–II adults planned to undergo FESS were given a standard general
anesthetic after which they were divided into 2 equal groups to receive either lidocaine infusion
in a dose of 1.5 mg/kg/h (group L, n= 24) or equal volumes of normal saline (group C,
n= 24). Primary outcome was the surgical ﬁeld rating score (0–5 points). Secondary outcomes
included hemodynamic parameters, extubation time, end-tidal sevoﬂurane concentrations, fentanyl
consumption, and postoperative visual analog pain scores (VASs).
Results: Both groupswere similar regarding hemodynamic parameters. Surgical ﬁeld scores were sig-
niﬁcantly lower in group L than in group C at all intraoperative time points (P< 0.05). Extubation
time was signiﬁcantly longer in group C than in group L [group C: 12.4(2.3) min and group L:
9.1(3) min, P= 0.03]. Intraoperative fentanyl dose was signiﬁcantly higher in group C than in group
L [group C: 172(37) mcg and group L: 149(34) mcg, P= 0.03]. End-tidal sevoﬂurane concentrations
were signiﬁcantly lower in group L than in group C at most intraoperative time points (P< 0.05).
Postoperative VAS pain scores in the PACU were higher in group C than in group L (P< 0.05).
296 A.M. OmarConclusion: This study showed the ability of intravenous lidocaine infusion of 1.5 mg/kg/h to pro-
duce controlled hypotension in patients undergoing FESS and the superiority of this technique over
placebo to achieve favorable surgical ﬁeld scoring.
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Controlled hypotension is one of the methods used by anesthe-
siologists to decrease intraoperative blood loss and provide a
good surgical ﬁeld in different types of surgery [1–4]. Func-
tional endoscopic sinus surgery (FESS) is one of the operations
that need controlled hypotension for this purpose [5,6].
Different types of drugs have been successfully used to pro-
vide deliberate hypotension such as inhalational volatile agents
[7], clonidine [4], nitroglycerine [8], esmolol [9], remifentanil
[10], dexmedetomidine [11], and magnesium sulfate [12–14].
Lidocaine is one of the most commonly used amide anes-
thetics. It can be safely given systemically to treat ventricular
arrhythmias [15] and blunt the pressor response to endotra-
cheal intubation [16]. Hypotension has been observed to occur
after submucosal injection of lidocaine [17,18]. Based on this
observation, I hypothesized that systemic lidocaine may be
effective in producing controlled hypotension. No studies were
found in the literature about the use of lidocaine in controlled
hypotension.
The aim of this study is to compare the possible ability of
lidocaine to produce controlled hypotension compared with
placebo in patients undergoing FESS.
2. Methods
Forty-eight adult (aged 18–50 yr) ASA physical status I and II
patients undergoing functional endoscopic sinus surgery
(FESS) were included in this study. A written informed con-
sent was obtained from all patients after approval by the Local
Ethics Committee. The enrollment period lasted from October
2011 to December 2012 in King Fahd Military Hospital in
Dhahran (KSA). Patients with hepatic, renal, cardiovascular,
neuromuscular, or hematological disorders were excluded. Pa-
tients on anticoagulant, opioid, or sedative drugs were also
excluded.
After applying the routine monitors (electrocardiogram,
pulse oximetry, noninvasive blood pressure, and peripheral
nerve stimulator over the ulnar nerve proximal to the wrist
crease to monitor the depth of neuromuscular blockade), all
patients were given a standardized general anesthetic and IV
ﬂuids (5–7 ml/kg/h of lactated Ringer). General anesthesia
was induced by 2–2.5 mg/kg propofol and 1–1.5 mcg/kg fenta-
nyl. Muscle relaxation was accomplished by rocuronium
0.6 mg/kg and tracheal intubation was done when train-of-
four (TOF) count reached zero.
Immediately after endotracheal intubation, patients were
randomly assigned to 2 equal groups using computerized ran-
domization tables (in closed envelopes): Control group (C,
n= 24) and group lidocaine (L, n= 24). The hospital phar-
macists who were not involved in the study prepared the study
medications in 4 different coded syringes (two 10-ml syringes
for boluses and two 50-ml syringes for infusion) and gave them
to the attendant anesthesiologist who was blinded to groupallocation. The 10-ml syringes for boluses contained either
1.5 mg/kg lidocaine (1% solution) for group L or equal vol-
ume of normal saline for group C. The 50-ml infusion syringes
contained either 1% lidocaine (10 mg/ml) in group L to be gi-
ven in a rate of 1.5 mg/kg/h (0.15 ml/kg/h) or equal volumes of
normal saline in control group. Lungs were mechanically ven-
tilated to normocarbia (monitored with end-tidal CO2) with
40% oxygen in medical air. Sevoﬂurane was used in 1–1.5
MAC (approximately 2–3%) to keep mean arterial pressure
(MAP) from 60 to 70 mmHg. Rocuronium boluses (5–10 mg)
were given to train-of-four (TOF) count less than 2. An oro-
pharyngeal pack was inserted after intubation, and then, the
patient was positioned in a slight head-up position. The sur-
geon was allowed to inject submucosal epinephrine in saline
(1:100,000) without lidocaine. If MAP was resistant to reach
the target or if heart rate increased more than 20% from base-
line, fentanyl 1 mcg/kg was given (every 30 min). If MAP was
still resistant after 5 min of every fentanyl bolus, a nitroglycer-
ine or esmolol infusion was titrated to effect on the discretion
of the attending anesthesiologist. Bradycardia (<48 bpm) was
treated by atropine 0.5 mg and hypotension
(MAP< 60 mmHg) was treated by phenylephrine boluses
(50–100 mcg) or infusion (50–100 mcg/min). The surgeons
who were blinded to group allocation were asked to assess
the surgical ﬁeld every 15 min according to this 6-point scale
[19]: (0= no bleeding, 1= slight bleeding–blood evacuation
not necessary, 2= slight bleeding-sometimes blood has to be
evacuated, 3= low bleeding-blood has to be often evacuated.
Operative ﬁeld is visible for some seconds after evacuation,
4= average bleeding-blood has to be often evacuated. Opera-
tive ﬁeld is visible only right after evacuation, 5= high bleed-
ing-constant blood evacuation is needed. Sometimes bleeding
exceeds evacuation. Surgery is hardly possible).
On conclusion of surgery, the study medications and sevo-
ﬂurane were discontinued. The effect of muscle relaxant was
antagonized by neostigmine 40–60 mcg/kg with glycopyrrolate
5–8 mcg/kg when TOF count was 3 or 4. Patients were extu-
bated while awake after removal of the oropharyngeal pack
and transferred to postanesthesia care unit (PACU). Pain
was assessed in PACU by a nurse who was blinded to group
allocation every 15 min by visual analog score (VAS) starting
from 0 (no pain) to 10 (worst imaginable pain). If pain VAS
score was 1–4, 30 mg of IV ketorolac was given. If pain score
>4 or if the pain was not relieved by ketorolac, fentanyl
0.5 mcg/kg was given. Ondansetron 4 mg IV was given as a
rescue antiemetic in case of postoperative nausea and vomiting
(PONV). Phenylephrine was used in PACU with the same
doses used intraoperatively to treat hypotension.
Primary outcome was the surgical ﬁeld quality. Based on a
pilot study conducted on 13 patients undergoing FESS in this
hospital (not published) and a previous study [20], median sur-
gical ﬁeld quality with sevoﬂurane was found to be 3.5(range
1–4). Difference of 1 grade in surgical ﬁeld quality was as-
sumed to be clinically signiﬁcant. Based on these data and
assumption, a sample size of 21 in each group was calculated
Table 2 Intraoperative quality of surgical ﬁeld (0–5 points).
Data are median (range).
Group C (n= 24) Group L (n= 24) P value
15 min 4(1–5) 2(1–4) 0.01*
30 min 4(1–4) 2(1–3) 0.02*
45 min 4(1–4) 2(1–3) 0.01*
60 min 3(1–4) 3(0–4) 0.02*
75 min 4(1–3) 2(0–3) 0.008*
90 min 4(1–4) 2(1–3) 0.02*
105 min 4(1–4) 3(1–3) 0.04*
Group C: control; group L: lidocaine.
* P< 0.05.
Figure 1 Mean (SD) heart rate in beats per min recorded at
different time points. No signiﬁcant differences. Group C: control;
group L: lidocaine.
Figure 2 Mean (SD) mean arterial pressure (MAP) recorded at
different time points. No signiﬁcant differences. Group C: control;
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tients were enrolled in each group to accommodate for drop-
outs and the ordinal nature of the primary outcome.
Secondary outcomes included HR and MAP recorded every
15 min intraoperatively, end-tidal sevoﬂurane every 15 min, to-
tal doses of fentanyl intra- and postoperatively, extubation
times (deﬁned as time from discontinuing sevoﬂurane till tra-
cheal extubation), estimated total blood loss in the suction
canister (after subtracting the volume of saline used in irriga-
tion), number of patients who needed treatment with atropine,
phenylephrine and nitroglycerine, pain VAS at 15, 30, and
60 min postoperatively in PACU, and incidence of PONV or
hypotension in the recovery room.
Data were statistically described in terms of mean (±SD),
median (range), frequencies (number of cases), and percent-
ages when appropriate. Data were tested ﬁrst for normal distri-
bution by Kolmogorov–Smirnov test. Comparison of
quantitative variables between the study groups was done
using Student t test for independent samples if normally dis-
tributed. Mann–Whitney U test was used for non-normally
distributed quantitative and ordinal data. For comparing cat-
egorical data, Chi square (v2) test was performed. Exact test
was used instead when the expected frequency is less than 5.
A probability value (p value) less than 0.05 was considered sta-
tistically signiﬁcant. All statistical calculations were done using
computer programs Microsoft Excel 2007 (Microsoft Corpora-
tion, NY, USA) and SPSS (Statistical Package for the Social
Science; SPSS Inc., Chicago, IL, USA) version 15 for Micro-
soft Windows.
3. Results
Seventy-seven patients were found eligible for the study. Nine
patients refused participation and 20 patients met the exclusion
criteria. Forty-eight patients were randomly allocated to 2
equal groups: control group (group C, n= 24) and lidocaine
group (group L, n= 24). Both groups were found to be similar
regarding demographic and surgical data except for anesthesia
time which was signiﬁcantly longer in group C than in group L
(Table 1). Surgical ﬁeld scores were signiﬁcantly lower in group
L than in group C at all intraoperative time points (Table 2).
Extubation time was signiﬁcantly longer in group C than in
group L [group C: 12.4(2.3) min and group L: 9.1(3) min,
P= 0.03].
Intraoperative fentanyl dose was signiﬁcantly higher in
group C than in group L [group C: 172(37) mcg and group
L: 149(34) mcg, P= 0.03].Table 1 Demographic and surgical data. Data are mean (SD) or number.
Group C (n= 24) Group L (n= 24) P value
Age (yr) 36.3(8.1) 36.7(7.7) 0.72
Gender (M/F) 14/10 13/11 0.81
BMI (kg/m2) 26.7(3.6) 27.9(3.2) 0.69
ASA (I/II) 17/7 15/9 0.61
Surgical time (min) 59(9) 62(8) 0.74
Anesthesia time (min) 99(13) 87(14) 0.02*
Estimated blood loss (ml) 106(29) 91(33) 0.13
M: male; F: female; BMI: body mass index; group C: control; group L: lidocaine.
* P< 0.05.
group L: lidocaine.
Figure 3 Mean (SD) end-tidal sevoﬂurane (ET sevo) concentra-
tions at different time points. Group C: control; group L:
lidocaine. \P< 0.05.
Table 3 Visual analog score (VAS) of pain in the PACU.
Group C (n= 24) Group L (n= 24) P value
VAS at 15 min 3(1–6) 2(1–5) 0.001*
VAS at 30 min 4(1–5) 3(1–4) 0.03*
VAS at 60 min 4(1–4) 3(1–4) 0.009*
Data are median (range group C: control; group L: lidocaine.
* P< 0.05.
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ative hemodynamics (Figs. 1 and 2). End-tidal sevoﬂurane
concentrations were signiﬁcantly lower in group L than in
group C at most intraoperative time points (Fig. 3).
One patient in group C and 2 patients in group L needed
atropine for intraoperative bradycardia (P= 0.61). Two pa-
tients in group C and 3 patients in group L needed intraoper-
ative use of phenylephrine (P= 0.66). Two patients in each
group needed rescue use of esmolol infusion (P= 1.0).
Postoperative VAS pain scores in the PACU were higher in
group C than in group L (Table 3). Nineteen patients in group
C and 13 patients in group L needed ketorolac (P= 0.13),
while seven patients in group C and only 3 patients in group
L needed fentanyl in PACU (P= 0.3). No patient in the study
had PACU hypotension.
Sixteen patients in group C and 11 patients in group L com-
plained of PONV in the PACU (P= 0.12).
4. Discussion
The main ﬁnding of this study is that intravenous lidocaine
infusion is an effective method in producing controlled hypo-
tension in patients undergoing FESS surgery, and it is more
superior to placebo in producing favorable surgical ﬁeld.
Deliberate hypotension is still widely used by anesthesiolo-
gists to decrease intraoperative blood loss and produce good
surgical ﬁelds in different types of surgery [1–4]. However,
the risk of organ hypoperfusion is a concern in this technique
[21]. Targeting a mean blood pressure of 60–70 mmHg was
considered safe as evidenced by normal metabolic and hor-
monal proﬁles in the form of serum lactate, pyruvate kinase,
and glucose [22,23]. Since then the target MAP of 60–
70 mmHg was used in most academic and clinical grounds.Several years after introduction of deliberate hypotension
in surgical practice, the consensus has been changed from
achieving a predeﬁned MAP to producing favorable surgical
ﬁelds [6,24,25]. Surgical ﬁeld scoring systems have been
adopted in clinical studies to compare between different tech-
niques of controlled hypotension and were found to be more
practical than achieving predeﬁned mean arterial pressures
[2,5,6,13,14,19,24,25]. Poor correlation was found between
the degree of hypotension and the quality of surgical ﬁeld
and consequently moderate hypotension did not necessarily
produce favorable surgical ﬁelds [6,25]. The investigators in
these 2 studies postulated that nitroprusside could not produce
good surgical ﬁeld rating because of its vasodilator effect.
Vasodilation might actually increase the vascularity of the mu-
cosa of the nasal sinuses and make the procedure more difﬁ-
cult. This hypothesis may be supported by the poorer results
of volatile anesthetics in comparison to other drugs used in
controlled hypotension [13,20]. Higher sevoﬂurane concentra-
tions in group C in this study may have resulted in more muco-
sal congestion than group L and consequently poorer surgical
ﬁeld. Moreover, there is some evidence that lidocaine can pro-
duce some degree of vasoconstriction in human. Jorfeldt et al.
[26] found that total systemic vascular resistance increased at
plasma lidocaine concentrations of 3–6 mcg/kg, and they pos-
tulated that vasoconstriction in some parts of the peripheral
circulation should have happened. The doses used in this study
were used in previous studies and resulted in serum lidocaine
levels less than 4 mcg/ml [27,28]. These relatively low plasma
lidocaine concentrations could have caused some degree of
mucosal vasoconstriction in the nasal sinuses and consequently
produced favorable surgical ﬁelds.
When given to awake patients, lidocaine did not cause
hypotension [29]. However, Enlund et al. noticed that submu-
cosal injection of lidocaine in the oral cavity resulted in a dose-
dependent decrease in MAP of anesthetized patients [17]. They
included a group of patients who received lidocaine without
epinephrine and found that this group also had a period of
post-inﬁltration hypotension. This observation might indicate
that hypotension did not result only from the probable b2-
receptor stimulation by epinephrine but also from a non-
understood mechanism of lidocaine. The authors postulated
that deep general anesthesia is a mandatory prerequisite of
hypotensive effects of lidocaine. The results of the current
investigation may support their notion. Despite of using lower
concentrations of sevoﬂurane in group L than in group C, the
achieved MAPs were similar.
There are 2 probable mechanisms of hypotensive ability of
lidocaine. The ﬁrst mechanism is the ability of all local anes-
thetics to exert dose-dependent negative inotropic action on
the heart by affecting calcium inﬂux [30]. This negative inotro-
pic effect of lidocaine may be aggravated by a similar effect of
volatile anesthetics. Inability of lidocaine to cause hypotension
in awake patients may suggest that its negative inotropic ac-
tion is weak. The second mechanism is the ability of lidocaine
to blunt the airway’s reﬂexes to endotracheal tube [31]. Lido-
caine infusion may have resulted in abolishing the patients’
sensation to endotracheal tubes, thus eliminating an important
mechanism of intraoperative sympathetic stimulation.
In spite of producing more favorable surgical ﬁeld scoring
in group L, the amount of blood loss in this group did not
reach a statistical signiﬁcance when compared to control
group. This may be explained by the underpowering of the
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blood loss estimation.
The decreased doses of fentanyl needed intraoperatively in
group L can be explained be the analgesic effect of lidocaine
which was previously demonstrated [32]. This may also re-
sulted in better postoperative analgesia and decreased need
to analgesics in PACU. This opioid-sparing effect of lidocaine
and the lowered sevoﬂurane concentrations might probably re-
sulted in shorter extubation time in group L.
The dose of lidocaine infusion in this study was used imper-
atively. No previous studies were found in the literature
regarding this use. However, this dose was safely used in stud-
ies of other purposes [27,28,32]. Future studies are needed to
compare the effects of different doses of lidocaine on the con-
duct of controlled hypotensive anesthesia.
In conclusion, this study showed the ability of intravenous
lidocaine infusion of 1.5 mg/kg/h to produce controlled hypo-
tension in patients undergoing FESS and the superiority of this
technique over placebo to achieve favorable surgical ﬁeld
scoring.
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